Trial intelligence / Profile preview

Venlafaxine versus duloxetine for knee osteoarthritis pain

ACTRN12619001082190Phase 4Recruiting

Sponsor
Waitematā District Health Board
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of venlafaxine and duloxetine in knee osteoarthritis (OA) (2 arms), sponsored by Waitematā District Health Board. Primary endpoint: Change in Brief Pain Inventory average pain rating. Started Sep 2019; status: recruiting.

02

Drugs

venlafaxineduloxetine
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on ACTRN12619001082190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12619001082190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call